Calla M. Olson

The paper introduces msDMS-MaP, a method to map RNA secondary, tertiary, and quaternary structures in living cells using multi-site DMS probing, revealing structural motifs and protein binding sites.

This study shows that combining CDK9 inhibitors with neuropsychiatric drugs reduces diffuse midline glioma growth by altering H3 dopaminylation and CaMKII signaling.

The paper investigates imacidin, a cyclic lipopeptide that inhibits the lipid II flippase MurJ, identifying it as a taxa-specific antibacterial agent with potential for precision antibiotics.